Difference between revisions of "Phosphatase Subfamily TAB1"

From PhosphataseWiki
Jump to: navigation, search
(Created page with "__NOTOC__ Phosphatase Classification: Fold PPM (PP2C): Superfamily PPM (PP2C): Phosph...")
 
(Function)
Line 13: Line 13:
 
* TAK1 <cite>Shibuya96</cite>
 
* TAK1 <cite>Shibuya96</cite>
 
* MEKK1 <cite>Charlaftis14</cite>. TAB1 is ubiquitinated by MEKK1 PHD domain.
 
* MEKK1 <cite>Charlaftis14</cite>. TAB1 is ubiquitinated by MEKK1 PHD domain.
+
 
 +
Human TAB1 is modified with N-acetylglucosamine (O-GlcNAc) on a single site, Ser-395. The modification is induced by IL-1 and osmotic stress, known inducers of the TAK1 signalling cascade. However, the serine at position 395 is only found in vertebrates.
 +
 
 
=== References ===
 
=== References ===
 
<biblio>
 
<biblio>

Revision as of 22:50, 8 June 2015

Phosphatase Classification: Fold PPM (PP2C): Superfamily PPM (PP2C): Family PPM (PP2C): Subfamily TAB1

Evolution

Domain

Function

Human TAB1 interacts with:

  • TRAF6 []
  • p38 [1, 2, 3]. TAB1 functions as a scaffold protein in the activation of p38 [3]
  • TAK1 [4]
  • MEKK1 [5]. TAB1 is ubiquitinated by MEKK1 PHD domain.

Human TAB1 is modified with N-acetylglucosamine (O-GlcNAc) on a single site, Ser-395. The modification is induced by IL-1 and osmotic stress, known inducers of the TAK1 signalling cascade. However, the serine at position 395 is only found in vertebrates.

References

  1. Ge B, Xiong X, Jing Q, Mosley JL, Filose A, Bian D, Huang S, and Han J. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta ), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J Biol Chem. 2003 Jan 24;278(4):2286-93. DOI:10.1074/jbc.M210918200 | PubMed ID:12429732 | HubMed [Ge02]
  2. Lanna A, Henson SM, Escors D, and Akbar AN. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol. 2014 Oct;15(10):965-72. DOI:10.1038/ni.2981 | PubMed ID:25151490 | HubMed [Lanna14]
  3. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, and Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science. 1996 May 24;272(5265):1179-82. DOI:10.1126/science.272.5265.1179 | PubMed ID:8638164 | HubMed [Shibuya96]
  4. Charlaftis N, Suddason T, Wu X, Anwar S, Karin M, and Gallagher E. The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. EMBO J. 2014 Nov 3;33(21):2581-96. DOI:10.15252/embj.201488351 | PubMed ID:25260751 | HubMed [Charlaftis14]
  5. Zhu Y, Regunath K, Jacq X, and Prives C. Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry. Genes Dev. 2013 Aug 15;27(16):1739-51. DOI:10.1101/gad.212258.112 | PubMed ID:23934659 | HubMed [Zhu14]
All Medline abstracts: PubMed | HubMed